101 related articles for article (PubMed ID: 27461622)
61. Flow cytometric Immunophenotyping and Hematological Findings at Diagnosis and Relapse of Pediatric Acute Lymphoblastic Leukemia Patients.
Gatavizadeh Z; Faranoush M; Shokouhian M; Azad VF; Saki N; Mousavei S; Bagheri M
Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337833
[TBL] [Abstract][Full Text] [Related]
62. GATA3 rs3824662 gene polymorphism as possible risk factor in a cohort of Egyptian patients with pediatric acute lymphoblastic leukemia and its prognostic impact.
Mosaad YM; Elashery R; Darwish A; Sharaf Eldein OA; Barakat T; Marouf S; Abou El-Khier NT; Youssef LF; Fawzy IM
Leuk Lymphoma; 2017 Mar; 58(3):689-698. PubMed ID: 27684731
[TBL] [Abstract][Full Text] [Related]
63. IL-35 and IL-18 Serum Levels in Children With Acute Lymphoblastic Leukemia: The Relationship With Prognostic Factors.
Solati H; Zareinejad M; Ghavami A; Ghasemi Z; Amirghofran Z
J Pediatr Hematol Oncol; 2020 May; 42(4):281-286. PubMed ID: 31764513
[TBL] [Abstract][Full Text] [Related]
64. Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia.
Ashry MSE; Radwan E; Abdellateif MS; Arafah O; Hassan NM
J Egypt Natl Canc Inst; 2023 Jun; 35(1):17. PubMed ID: 37303010
[TBL] [Abstract][Full Text] [Related]
65. Increased expression of costimulatory molecules CD86 and sCTLA-4 in patients with acute lymphoblastic leukemia.
Mansour A; Elkhodary T; Darwish A; Mabed M
Leuk Lymphoma; 2014 Sep; 55(9):2120-4. PubMed ID: 24283754
[TBL] [Abstract][Full Text] [Related]
66. Survival of children diagnosed with acute lymphoblastic leukemia in 1977-82 in Connecticut.
Polednak AP
J Clin Epidemiol; 1989; 42(7):617-23. PubMed ID: 2760654
[TBL] [Abstract][Full Text] [Related]
67. Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia.
Sauerbrey A; Zintl F; Volm M
Ann Hematol; 1994 Sep; 69(3):111-5. PubMed ID: 8086505
[TBL] [Abstract][Full Text] [Related]
68. Prognostic factors in childhood acute lymphoblastic leukaemia.
Armstrong J; Pomeroy M; Fennelly JJ; Cahalane S
Ir J Med Sci; 1990 Feb; 159(2):40-3. PubMed ID: 2347677
[TBL] [Abstract][Full Text] [Related]
69. [Expression of Ki-67 in Adult and Children Acute Lymphoblastic Leukemia and Its Clinical Significance].
Chen H; Yuan FF; Ai H; Chen L; Mi RH; Li MJ; Yin QS; Wang XJ; Fan RH; Wei XD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):70-76. PubMed ID: 29397821
[TBL] [Abstract][Full Text] [Related]
70. Higher baseline natural killer cell counts are associated with a lower 8-day blast count and lower day 33 minimal residual disease in children with pediatric B-acute lymphoblastic leukemia.
Sharma N; Gupta R; Kotru M; Gomber S; Gautam HV
Am J Blood Res; 2023; 13(1):53-60. PubMed ID: 36937457
[TBL] [Abstract][Full Text] [Related]
71. Correlation between early treatment failure and Ki67 antigen expression in blast cells of children with acute lymphoblastic leukaemia before commencing treatment. A retrospective study.
Nowicki M; Miśkowiak B; Kaczmarek-Kanold M
Oncology; 2002; 62(1):55-9. PubMed ID: 11810044
[TBL] [Abstract][Full Text] [Related]
72. [Change of ROCK1 Gene Expression Level in Patients with Acute Lymphoblastic Leukemia and Its Clinical Significance].
He WH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):415-420. PubMed ID: 30998147
[TBL] [Abstract][Full Text] [Related]
73. The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia.
M Kamazani F; Bahoush-Mehdiabadi G; Aghaeipour M; Vaeli S; Amirghofran Z
Iran J Pediatr; 2014 Aug; 24(4):371-80. PubMed ID: 25755857
[TBL] [Abstract][Full Text] [Related]
74. Monoclonal Antibodies 13A4 and AC133 Do Not Recognize the Canine Ortholog of Mouse and Human Stem Cell Antigen Prominin-1 (CD133).
Thamm K; Graupner S; Werner C; Huttner WB; Corbeil D
PLoS One; 2016; 11(10):e0164079. PubMed ID: 27701459
[TBL] [Abstract][Full Text] [Related]
75. Haemoglobin and prognosis in childhood acute lymphoblastic leukaemia.
Hann IM; Scarffe JH; Palmer MK; Evans DI; Jones PH
Arch Dis Child; 1981 Sep; 56(9):684-6. PubMed ID: 6945824
[TBL] [Abstract][Full Text] [Related]
76. Prognostic Role of CD200 in Acute Lymphoblastic Leukemia Patients.
Khalil M; Elsharkawy N; Elmawardy MM; Ayoub MA
Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673136
[TBL] [Abstract][Full Text] [Related]
77. Biochemical and Hematologic Profiles in B-Cell Acute Lymphoblastic Leukemia Children.
Khalid A; Ahmed M; Hasnain S
J Pediatr Hematol Oncol; 2023 Oct; 45(7):e867-e872. PubMed ID: 37526363
[TBL] [Abstract][Full Text] [Related]
78. Prognostic-significance of protein-kinase-C in newly-diagnosed childhood acute lymphoblastic-leukemia.
Volm M; Sauerbrey A; Zintl F
Int J Oncol; 1994 Feb; 4(2):363-8. PubMed ID: 21566933
[TBL] [Abstract][Full Text] [Related]
79. Serum Survivin and TP53 Gene Expression in Children with Acute Lymphoblastic Leukemia.
Yahya RS; Fouda MI; El-Baz HA; Mosa TE; Elmaksoud MD
Iran J Public Health; 2012; 41(1):37-44. PubMed ID: 23113120
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
